Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 399

1.

Coping style and ecstasy use motives as predictors of current mood symptoms in ecstasy users.

Scott RM, Hides L, Allen JS, Lubman DI.

Addict Behav. 2013 Oct;38(10):2465-72. doi: 10.1016/j.addbeh.2013.05.005. Epub 2013 May 12.

PMID:
23770644
2.

Depressive and anxiety symptomatology in ecstasy users: the relative contribution of genes, trauma, life stress and drug use.

Scott RM, Hides L, Allen JS, Burke R, Lubman DI.

Psychopharmacology (Berl). 2010 Mar;209(1):25-36. doi: 10.1007/s00213-009-1763-5. Epub 2010 Jan 26.

PMID:
20101393
3.

Subacute effects of ecstasy on mood: an exploration of associated risk factors.

Scott RM, Hides L, Allen JS, Lubman DI.

J Psychopharmacol. 2013 Jan;27(1):53-61. doi: 10.1177/0269881112463467. Epub 2012 Oct 24.

PMID:
23095244
4.

Pathways to ecstasy use in young adults: anxiety, depression or behavioural deviance?

Alati R, Kinner SA, Hayatbakhsh MR, Mamun AA, Najman JM, Williams GM.

Drug Alcohol Depend. 2008 Jan 1;92(1-3):108-15. Epub 2007 Sep 11.

PMID:
17850992
5.
6.

Ecstasy use and depression: a 4-year longitudinal study among an Australian general community sample.

George AM, Olesen S, Tait RJ.

Psychopharmacology (Berl). 2013 Oct;229(4):713-21. doi: 10.1007/s00213-013-3132-7. Epub 2013 May 17.

PMID:
23681160
7.

Prevalence of internet addiction and its association with stressful life events and psychological symptoms among adolescent internet users.

Tang J, Yu Y, Du Y, Ma Y, Zhang D, Wang J.

Addict Behav. 2014 Mar;39(3):744-7. doi: 10.1016/j.addbeh.2013.12.010. Epub 2013 Dec 18.

PMID:
24388433
8.

Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation.

Daumann J, Hensen G, Thimm B, Rezk M, Till B, Gouzoulis-Mayfrank E.

Psychopharmacology (Berl). 2004 May;173(3-4):398-404. Epub 2004 Jan 14.

PMID:
14722704
9.

Are childhood trauma exposures predictive of anxiety sensitivity in school attending youth?

Martin L, Viljoen M, Kidd M, Seedat S.

J Affect Disord. 2014 Oct;168:5-12. doi: 10.1016/j.jad.2014.06.035. Epub 2014 Jul 2.

PMID:
25033472
10.

Resilience, self-efficacy, coping styles and depressive and anxiety symptoms in those newly diagnosed with multiple sclerosis.

Tan-Kristanto S, Kiropoulos LA.

Psychol Health Med. 2015;20(6):635-45. doi: 10.1080/13548506.2014.999810. Epub 2015 Jan 14.

PMID:
25588098
11.

[Emotion regulation among psychostimulants drug users at techno parties].

Lillaz C, Varescon I.

Encephale. 2012 Oct;38(5):390-6. doi: 10.1016/j.encep.2011.11.009. Epub 2012 Jan 5. French.

PMID:
23062452
12.

Club drug use in Germany.

Soellner R.

Subst Use Misuse. 2005;40(9-10):1279-93.

PMID:
16048817
13.

Patterns of ecstasy use in Australia: findings from a national household survey.

Degenhardt L, Barker B, Topp L.

Addiction. 2004 Feb;99(2):187-95.

PMID:
14756711
14.

Is emotional intelligence impaired in ecstasy-polydrug users?

Craig L, Fisk JE, Montgomery C, Murphy PN, Wareing M.

J Psychopharmacol. 2010 Feb;24(2):221-31. doi: 10.1177/0269881108095713. Epub 2008 Sep 18.

PMID:
18801831
15.

Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.

Bedi G, Van Dam NT, Redman J.

J Psychopharmacol. 2010 Feb;24(2):233-40. doi: 10.1177/0269881108097631. Epub 2008 Oct 2.

PMID:
18832429
16.

Mental disorders in current and former heavy ecstasy (MDMA) users.

Thomasius R, Petersen KU, Zapletalova P, Wartberg L, Zeichner D, Schmoldt A.

Addiction. 2005 Sep;100(9):1310-9.

PMID:
16128720
17.

Contextualising psychological distress among regular ecstasy users: the importance of sociodemographic factors and patterns of drug use.

George J, Kinner SA, Bruno R, Degenhardt L, Dunn M.

Drug Alcohol Rev. 2010 May;29(3):243-9. doi: 10.1111/j.1465-3362.2009.00159.x.

PMID:
20565515
18.

The association between the negative effects attributed to ecstasy use and measures of cognition and mood among users.

Fisk JE, Montgomery C, Murphy PN.

Exp Clin Psychopharmacol. 2009 Oct;17(5):326-36. doi: 10.1037/a0017038.

PMID:
19803632
19.

Modelling the adverse effects associated with ecstasy use.

Fisk JE, Murphy PN, Montgomery C, Hadjiefthyvoulou F.

Addiction. 2011 Apr;106(4):798-805. doi: 10.1111/j.1360-0443.2010.03272.x. Epub 2010 Dec 23.

PMID:
21182557
20.

The harmful health effects of recreational ecstasy: a systematic review of observational evidence.

Rogers G, Elston J, Garside R, Roome C, Taylor R, Younger P, Zawada A, Somerville M.

Health Technol Assess. 2009 Jan;13(6):iii-iv, ix-xii, 1-315. doi: 10.3310/hta13050. Review.

Supplemental Content

Support Center